The decision to purchase credit insurance is an individual one and must be tailor made to the individual’s credit picture, and the likelihood that his or her earning capacity may be interrupted. It is obvious that if you have little of no debt, credit insurance is not for you. But for most Americans who routine carry a debt load that includes a car and several credit card lines of credit, credit insurance may be in order. If the individual’s place of residence, whether it is a house or a condominium apartment is mortgages, then either credit or mortgage insurance is a necessity.
Like many of us you have probably wished at some time that all of your debts were cancelled. New types of insurance may make this no longer a pipedream, but a reasonable alternative to credit insurance.
Credit Insurance is an insurance policy that is usually offered by a credit card company or unsecured small loan lender, and is associated with the debt incurred by a loan or line of credit. It assures that the payments will continue to be made to the lender, in the usual and pre-agreed upon amount, according to the terms of the loan in the event that the debtor is unable to financially make payments for a time period. This situation may arise if the individual becomes ill, has an accident, or becomes involuntarily unemployed, and has no or a limited income. It assures that the creditor is paid, and gives the debtor a feeling of peace of mind.
Credit insurance is designed to bring peace of mind to people who want to protect their assets and ensure their financial security in times of involuntary income loss. However, some consumer advocates say credit insurance is overpriced at best, and is empty coverage that most people could do without.
Pharmaceutical companies began forming in the late 1800s for the purpose of developing and selling drugs and healthcare related products. Many grew as an offshoot of existing chemical companies.
The term "Orphan Drugs" refers to medicinal products that are produced for the diagnosis, prevention or treatment of life-threatening or very serious, but rare, diseases. In the United States, an Orphan disease is one that affects less than 200,000 persons in the country. These drugs are termed "orphans" because the pharmaceutical industry has little interest in developing and marketing products intended for only a small number of patients suffering from very rare conditions. Orphan Drugs research and development is not cost effective.
The regulation of the products and drugs produced by Pharmaceutical Companies is under the auspices of the Food and Drug Administration (FDA) in the United States and the European Agency for the Evaluation of Medicinal Products (EMEA) in the European Union. The agencies must approve and license a product before it can be released on the market. Both serve as consumer watchdogs and seek to protect the consumer.
In the 1980's, biotechnology became the darling of the pharmaceutical industry. Both biotechnology and pharmaceutical companies have the same goal of discovering, developing and selling products that will aid the health of humans and animals. However, biotechnology, a science based upon the newly acquired ability to manipulate the DNA molecule, offered new approaches to drug design and development.
The estimate of the cost involved in developing a new drug has risen from one billion United States dollars to around 1.7 billion dollars, where it currently rests. These costs arise primarily from the extensive testing required for licensing prior to marketing a drug. Clinical trials on human beings and safety monitoring of the product take years to assemble the information and data required to satisfy the FDA (Food and Drug Administration) and to become approved by this agency.
The most important advantage of being in the computer network business is the promotions and also the competitions which help to prosper in life. Promotional strategies are implemented which would help you to distinguish between various competitions such as word of mouth, publicity, advertising and even networking.
444 Articles, Page 11 of 45
<< 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ...
45 >>